- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Myeloid Leukaemia Recurrent in New Zealand
Total 1255 results
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States, Spain, Canada, Israel, Korea, Republic of, Taiwan, France, Australia, Germany, Mexico, Japan, Sweden, China, Austria, Belgium, Czechia, Hungary, Italy, Poland, Romania, Russian Federation, United Kingdom
-
University of Maryland, BaltimoreNational Cancer Institute (NCI)Completed
-
Aptose Biosciences Inc.Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Hoffmann-La RocheCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
CelgeneApproved for marketing
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
Center for International Blood and Marrow Transplant...National Marrow Donor ProgramRecruitingAcute Myeloid Leukemia in RemissionUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada
-
University Hospital MuensterCharite University, Berlin, Germany; Hannover Medical School; University Hospital... and other collaboratorsTerminatedAcute Myeloid LeukemiaGermany
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myelogenous LeukemiaUnited States
-
Kura Oncology, Inc.RecruitingNeoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL RearrangementUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsNo longer availableAcute Myeloid Leukemia (AML) With | FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)United States
-
Telios Pharma, Inc.Kartos Therapeutics, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Korea, Republic of, Spain, France, Austria, Australia, Germany, Italy
-
Center for International Blood and Marrow Transplant...National Marrow Donor ProgramRecruitingLymphoma | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Acute Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Mixed Phenotype Acute LeukemiaUnited States
-
Jazz PharmaceuticalsCompletedTherapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With Myelodysplasia-Related ChangesUnited States
-
GlycoMimetics IncorporatedActive, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Spain, Australia, Netherlands, France, Ireland, Italy, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)Terminated
-
Eisai Inc.CompletedAcute Myeloid LeukemiaUnited States, Poland, Australia, Spain, France, Canada, Mexico, Romania, Taiwan, Russian Federation, Hungary, Serbia, Croatia, United Kingdom, Czechia
-
Cleave Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Acute Myeloid Leukemia, in RelapseUnited States, Australia
-
Calithera Biosciences, IncCompletedAcute Myeloid Leukemia (AML) | Acute Lymphocytic Leukemia (ALL)United States
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Kronos BioTerminatedNucleophosmin 1-mutated Acute Myeloid LeukemiaIsrael, Spain, France, United States, Czechia, Hungary, Korea, Republic of, Germany, Italy, Poland, Brazil, Canada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Terminated
-
Syndax PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Undifferentiated Leukemia | Relapsed/Refractory Leukemias | Mixed Phenotype Acute LeukemiaUnited States, Canada
-
University of RochesterCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
Ascenta TherapeuticsThe Leukemia and Lymphoma SocietyTerminated
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaKorea, Republic of, United States, Spain, Belgium, Germany, Czechia, Hungary, Taiwan, France, Israel, Italy, United Kingdom, Australia, Austria, Poland, Luxembourg
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Stemline Therapeutics, Inc.The Leukemia and Lymphoma SocietyCompletedAcute Myeloid Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)United States
-
Opna-IO LLCCompletedHigh-risk Myelodysplastic Syndrome (MDS) | Relapsed Acute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML)United States
-
Hackensack Meridian HealthCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruiting
-
Christian Medical College, Vellore, IndiaMinistry of Science and Technology, IndiaUnknownAcute Promyelocytic LeukemiaIndia
-
Xanthus Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States, Canada
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedMyelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Natural Killer Cell Lymphoblastic Leukemia/LymphomaUnited States, Australia, Canada
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
Janssen Research & Development, LLCCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Spain, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
Eisai Inc.TerminatedPediatric Acute Myelogenous Leukemia (AML)United States, Canada, Australia
-
Eleos, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, Netherlands, Canada, France, Germany, United Kingdom, Italy, Poland
-
ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
AbbVieRecruiting
-
NovartisCompletedLeukemiaUnited States